Ebola | ||||||
NEWS | ||||||
New breakthrough achieved in inhibiting Ebola virus Researchers have identified an enzyme that can be inhibited to stop the spread of the deadly Ebola virus. A team from the University of Copenhagen and Phillips Universitat Marburg in Germany have isolated a critical new host factor for the virus, which uses a small part of the host's own cells to copy ...
| ||||||
Inovio Poised For Breakthroughs In 2018 And Beyond The FDA Emergency Use Authorization (EUA) has at least 3 vaccines (Ebola, MERS, Zika) and less likely a 4th (H7N9 influenza), which Inovio could bring to market over the next 3 years. An EUA approval could yield a priority review voucher (PRV) from the FDA which has a worth of roughly $350 million ...
| ||||||
Progress being made in future vaccines to prevent diseases Ebola. A early-stage trial of 75 healthy volunteers found that the vaccine gave an immune response for a full year in 100% of the patients. A larger-scale trial will have to prove if the longer-lasting vaccine is effective at preventing the disease. Norovirus. A company called Vaxart is developing a tablet ...
| ||||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar